FDA steps back from wearables. The checking now falls to you.

What actually changed?

The line between a "general wellness product" and a regulated medical device has always been drawn by the claim, not the sensor. A ring that tells you about your sleep is wellness; a ring that tells you that you have sleep apnoea is a device. The January guidance widens the wellness side of that line and states the agency's intent not to enforce device requirements across it.

Nothing about the underlying hardware changed. What changed is how much a company has to prove before selling it.

Who checks the claims now?

Increasingly: platforms, publishers and buyers. It's notable that as the FDA loosened, Apple tightened — expanding its own health-app requirements for the App Store. When a private platform's review policy becomes a stricter gate than the federal one, the shape of the market changes in ways that are hard to see from the outside.

For readers, the practical consequence is that "FDA" appearing anywhere near a wellness product tells you even less than it used to. The questions worth asking are unchanged: what was this validated against, in how many people, and who paid for the study.

What we're changing

Our Evidence & claims axis already penalises unsourced or company-funded claims. From this quarter we're also flagging, in every review, whether a product has been through any formal regulatory review at all — because a reader can no longer infer it from the category.